LEADER 01516nam0 22003493i 450 
001 VAN00296967
005 20250721104915.992
017 70$2N$a9783030971823
100   $a20250721d2022       |0itac50      ba
101   $aeng
102   $aCH
105   $a||||    |||||
181   $ai$b   e  
182   $ab
183   $acr
200 1 $aNeuroproteomics as a Tool for Understanding Schizophrenia$fDaniel Martins-de-Souza editor
210   $aCham$cSpringer$d2022
215   $aVIII, 143 p.$cill.$d24 cm
410  1$1001VAN00064096$12001 $aAdvances in Experimental Medicine and Biology$1210  $aNew York$cPlenum$d2003-$v1400
620   $aCH$dCham$3VANL001889
676   $a576.5$cGenetica$v22
676   $a570.285$cBioinformatica$v22
702  1$aMartins-de-Souza$bDaniel$3VANV252606
712   $aSpringer <editore>$3VANV108073$4650
801   $aIT$bSOL$c20250725$gRICA
856 4 $uhttps://link.springer.com/book/10.1007/978-3-030-97182-3$zE-book - Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$1IT-CE0101$2VAN17
912   $fN
912   $aVAN00296967
950   $aBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$d17CONS      e-book                  2396        $e17BIB2396/500  500     20250721            
996   $aNeuroproteomics As a Tool for Understanding Schizophrenia$92904878
997   $aUNICAMPANIA